|
| 37827694 | EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. | Ann Rheum Dis | 2024 |
| 34962100 | Evaluating the Construct of Damage in Systemic Lupus Erythematosus. | Arthritis Care Res (Hoboken) | 2023 |
| 35961031 | Antiphospholipid antibodies in patients with calcific aortic valve stenosis. | Rheumatology | 2023 |
| 35642868 | Anti-phosphatidylserine/prothrombin antibodies and thrombosis associate positively with HLA-DRB1*13 and negatively with HLA-DRB1*03 in SLE. | Rheumatology | 2023 |
| 37673226 | The expression of antibodies to Z-DNA in the blood of patients with systemic lupus erythematosus: Relationship to autoantibodies to B-DNA. | | 2023 |
| 37993371 | Systemic lupus erythematosus and damage: What has changed over the past 20 years? | Best Pract Res Clin Rheumatol | 2023 |
| 36508734 | Urine Galectin-3 binding protein reflects nephritis activity in systemic lupus erythematosus. | | 2023 |
| 37439924 | Urinary aberrations in systemic lupus erythematosus not always indicative of lupus nephritis: a cross-sectional cohort study. | | 2023 |
| 37349744 | Low-density granulocytes are related to shorter pregnancy duration but not to interferon alpha protein blood levels in systemic lupus erythematosus. | | 2023 |
| 35110331 | EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome. | Annals of the Rheumatic Diseases | 2022 |
| 35974709 | Long-term prognosis after a first myocardial infarction: eight years follow up of the case-control study PAROKRANK. | Scand Cardiovasc J | 2022 |
| 36104119 | Interleukin (IL) 16: a candidate urinary biomarker for proliferative lupus nephritis. | Lupus Science and Medicine | 2022 |
| 36332927 | Mer-tyrosine kinase: a novel susceptibility gene for SLE related end-stage renal disease. | Lupus Sci Med | 2022 |
| 35729719 | Strong Association of Combined Genetic Deficiencies in the Classical Complement Pathway With Risk of Systemic Lupus Erythematosus and Primary Sjögren's Syndrome. | Arthritis Rheumatol | 2022 |
| 35315244 | Complement C4 Copy Number Variation is Linked to SSA/Ro and SSB/La Autoantibodies in Systemic Inflammatory Autoimmune Diseases. | Arthritis Rheumatol | 2022 |
| 34853085 | Gestational Diabetes Mellitus Risk in Pregnant Women With Systemic Lupus Erythematosus. | Journal of Rheumatology | 2022 |
| 35246487 | Inflammatory markers in saliva and urine reflect disease activity in patients with systemic lupus erythematosus. | Lupus Science and Medicine | 2022 |
| 35207282 | Antibodies to Are Increased in Patients with Severe Periodontitis, and Associate with Presence of Specific Autoantibodies and Myocardial Infarction. | Journal of Clinical Medicine | 2022 |
| 34658170 | Four Systemic Lupus Erythematosus Subgroups, Defined by Autoantibodies Status, Differ Regarding HLA-DRB1 Genotype Associations and Immunological and Clinical Manifestations. | ACR Open Rheumatology | 2022 |
| 34820922 | Antiphospholipid antibodies in patients with myocardial infarction with and without obstructive coronary arteries. | Journal of Internal Medicine | 2022 |
| 34471268 | Publisher Correction: Global epidemiology of systemic lupus erythematosus. | Nature reviews. Rheumatology | 2021 |
| 32004410 | Maternal Hypertensive Disorders in Pregnant Women With Systemic Lupus Erythematosus and Future Cardiovascular Outcomes. | Arthritis Care and Research | 2021 |
| 34295471 | Systematic evaluation of SARS-CoV-2 antigens enables a highly specific and sensitive multiplex serological COVID-19 assay. | Clin Transl Immunology | 2021 |
| 34127828 | Variants in BANK1 are associated with lupus nephritis of European ancestry. | Genes and Immunity | 2021 |
| 33972457 | Quick Systemic Lupus Activity Questionnaire (Q-SLAQ): a simplified version of SLAQ for patient-reported disease activity. | Lupus Science and Medicine | 2021 |
| 34290127 | Myocardial infarctions, subtypes and coronary atherosclerosis in SLE: a case-control study. | Lupus Science and Medicine | 2021 |
| 33957795 | Associations with thrombosis are stronger for antiphosphatidylserine/prothrombin antibodies than for the Sydney criteria antiphospholipid antibody tests in SLE. | Lupus | 2021 |
| 33685997 | Activated low-density granulocytes in peripheral and intervillous blood and neutrophil inflammation in placentas from SLE pregnancies. | Lupus Science and Medicine | 2021 |
| 34162597 | Quality indicators for systemic lupus erythematosus based on the 2019 EULAR recommendations: development and initial validation in a cohort of 220 patients. | Annals of the Rheumatic Diseases | 2021 |
| 34046573 | Factors associated with self-reported capacity to walk, jog and run in individuals with systemic lupus erythematosus. | | 2021 |
| 34093522 | A Comprehensive Evaluation of the Relationship Between Different IgG and IgA Anti-Modified Protein Autoantibodies in Rheumatoid Arthritis. | Frontiers in Immunology | 2021 |
| 33931094 | Proteome study of cutaneous lupus erythematosus (CLE) and dermatomyositis skin lesions reveals IL-16 is differentially upregulated in CLE. | | 2021 |
| 33766895 | Interaction between the rs11889341(T) risk allele and smoking confers increased risk of myocardial infarction and nephritis in patients with systemic lupus erythematosus. | Annals of the Rheumatic Diseases | 2021 |
| 34345022 | Global epidemiology of systemic lupus erythematosus. | Nature reviews. Rheumatology | 2021 |
| 34335613 | DNA Methylation-Based Interferon Scores Associate With Sub-Phenotypes in Primary Sjögren's Syndrome. | Frontiers in Immunology | 2021 |
| 33377143 | Erratum to: Interferon activation status underlies higher antibody response to viral antigens in patients with systemic lupus erythematosus receiving no or light treatment. | Rheumatology | 2021 |
| 32994161 | Toll-like receptors revisited; a possible role for TLR1 in lupus nephritis. | Ann Rheum Dis | 2021 |
| 33037003 | Molecular pathways in patients with systemic lupus erythematosus revealed by gene-centred DNA sequencing. | Ann Rheum Dis | 2021 |
| 33006609 | Interferon activation status underlies higher antibody response to viral antigens in patients with systemic lupus erythematosus receiving no or light treatment. | Rheumatology | 2021 |
| 32724065 | Contributions of de novo variants to systemic lupus erythematosus. | European Journal of Human Genetics | 2021 |
| 33412597 | The Complex Relationship between C4b-Binding Protein, Warfarin, and Antiphospholipid Antibodies. | Thrombosis and Haemostasis | 2021 |
| 34930819 | Impact of glucocorticoids on the incidence of lupus-related major organ damage: a systematic literature review and meta-regression analysis of longitudinal observational studies. | Lupus Sci Med | 2021 |
| 34526357 | Infection hospitalisation in systemic lupus in Sweden. | Lupus Science and Medicine | 2021 |
| 31411331 | Sudanese and Swedish patients with systemic lupus erythematosus: immunological and clinical comparisons. | Rheumatology | 2020 |
| 32027083 | Experiences of physical activity and exercise in individuals with systemic sclerosis: A qualitative study. | Practice Development in Health Care | 2020 |
| 32430402 | Could severe COVID-19 be considered a complementopathy? | Lupus Science and Medicine | 2020 |
| 32259250 | Complement deposition, C4d, on platelets is associated with vascular events in systemic lupus erythematosus. | Rheumatology | 2020 |
| 31957081 | The antiphospholipid syndrome - often overlooked cause of vascular occlusions? | Journal of Internal Medicine | 2020 |
| 31826855 | High genetic risk score is associated with early disease onset, damage accrual and decreased survival in systemic lupus erythematosus. | Annals of the Rheumatic Diseases | 2020 |
| 31722419 | ALCAM and VCAM-1 as urine biomarkers of activity and long-term renal outcome in systemic lupus erythematosus. | Rheumatology | 2020 |